Confronto
Octreotide vs. Plecanatid
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Ricerca (altro)
Ricerca (altro)
N. CAS
83150-76-9
467426-54-6
Peso molecolare
1019.24 g/mol
1682 g/mol
Emivita
1.7 h
nessun dato
Sequenza
D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr(ol)nessun dato
Meccanismo d'azione
Octreotide
Octreotide is a cyclic octapeptide that selectively binds somatostatin-receptor subtypes SSTR2 and SSTR5. Via G-protein-coupled signalling, adenylyl cyclase is inhibited, reducing the secretion of multiple hormones (growth hormone, IGF-1, glucagon, insulin, VIP, serotonin). Structural stabilisation via a disulfide bridge and D-amino acids extends the half-life relative to natural somatostatin (minutes to several hours).
Plecanatid
Plecanatide is structurally analogous to the body's own uroguanylin and, like it, activates the GC-C receptor at the gut surface, raising cGMP and fluid secretion. Its pH-dependent activity shifts the effect toward the proximal small intestine.
Base di evidenze
Evidenza più alta
RCT sull'uomo
RCT sull'uomo
Studi
5
0
di cui sull'uomo
4
0
Effetti registrati
3
2
Contraddizioni aperte
1
1
Eventi avversi documentati
2
1
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Octreotide and Plecanatid?
- Octreotide is classified as "Ricerca (altro)", while Plecanatid is classified as "Ricerca (altro)". Octreotide: Synthetic octapeptide somatostatin analog with a longer half-life than endogenous somatostatin. FDA- and EMA-approved since the 1980s for acromegaly and neuroendocrine tumours. Plecanatid: Plecanatide is a 16-amino-acid analog of the body's own uroguanylin and a guanylate cyclase-C (GC-C) agonist. It is approved for chronic idiopathic constipation (CIC) and IBS with constipation (IBS-C). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Octreotide or Plecanatid?
- The highest available evidence level is "RCT sull'uomo" for Octreotide and "RCT sull'uomo" for Plecanatid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Octreotide and Plecanatid in Germany and the United States?
- Germania: Octreotide — Su prescrizione, Plecanatid — Non approvato. Stati Uniti: Octreotide — Su prescrizione, Plecanatid — Su prescrizione. These are factual summaries with source and review date on the individual pages.